Wuhan Weirun Bafang Medical Technology develops minimally invasive devices for urological conditions.
Established in 2020 and based in Wuhan, China, Wuhan Weirun Bafang Medical Technology develops medical devices for urology. Its development programs address lower urinary tract symptoms, urinary stones, and urinary tract tumors. The company is conducting multicenter clinical trials at hospitals including the General Hospital of the People's Liberation Army, Tongji Hospital, and West China Hospital. One product is a transurethral prostate bundle nail implant intended to reduce surgery and recovery time.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Wuhan Weirun Bafang Medical Technology? This is my company